Virtual Medicinal Product (VMP)
-
Papaveretum 15.4mg/1ml solution for injection ampoules
Name Details
Current Name
Papaveretum 15.4mg/1ml solution for injection ampoules
|
Start Date
21-06-2004
|
End Date
|
Previous Name
Papaveretum 15.4mg/ml injection 1ml ampoules
|
Start Date
13-03-2003
|
End Date
20-06-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 2 (CD)
- Route
- Intramuscular, Intravenous, Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular, solutioninjection.intravenous, solutioninjection.subcutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
-
N02AA10
BNF |
Current BNF
04070200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04070200
|
Start Date
21-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
14612711000001102 |
30-10-2008 |
|
333960003 |
13-03-2003 |
29-10-2008 |
VMP Ingredients
VMP ingredients table
Papaveretum |
Based on Ingredient Substance |
|
15.4 mg |
1 ml |
Name
Papaveretum
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
15.4
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Papaveretum
-
VMP
(Current) Papaveretum 15.4mg/1ml solution for ...
Virtual Medicinal Product Pack (VMPP) Information